About Varro Life Sciences
Varro Life Sciences is a company based in New York (United States) founded in 2020. It operates as a Open Source. Varro Life Sciences has raised $20 million across 1 funding round from investors including Vitalik Buterin. Varro Life Sciences offers products and services including Biodetector Device and Pathogen Detection Platform. Varro Life Sciences operates in a competitive market with competitors including Noze, Poppy, Steradian Technologies and Sonolux Healthtech, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Y2x Life Sciences
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Angel Round
Oct 31, 2024
-
Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Varro Life Sciences
Varro Life Sciences offers a comprehensive portfolio of products and services, including Biodetector Device and Pathogen Detection Platform.
Device for rapid detection of aerosolized pathogens in breath and air.
Platform combining electronics for ultrafast infectious disease testing.
Funding Insights of Varro Life Sciences
Varro Life Sciences has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Angel Round of $20 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Varro Life Sciences
Varro Life Sciences has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Vitalik Buterin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VB
Vitalik Buterin |
-
|
Locked | Locked | Locked |
Investor details for Varro Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Varro Life Sciences
Investment portfolio details for Varro Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Varro Life Sciences
Detailed financials for Varro Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Varro Life Sciences Comparisons
Peer comparison for Varro Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Varro Life Sciences
Varro Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noze, Poppy, Steradian Technologies and Sonolux Healthtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of AI-based platform for air-borne disease detection
|
|
| Locked | Locked | Locked |
Provider of pathogen sensing and detection system
|
|
| Locked | Locked | Locked |
Developer of a diagnostic device for infectious pathogen detection
|
|
| Locked | Locked | Locked |
Air-based virus detection systems are provided via Photonic PCR technology.
|
Detailed competitors of Varro Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Varro Life Sciences
Complete news archive for Varro Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Varro Life Sciences
Varro Life Sciences was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Varro Life Sciences is headquartered in New York, United States. It is registered at New York, New York, United States.
Varro Life Sciences is a funded company, having raised a total of $20M across 1 funding round to date.
Varro Life Sciences focuses on creating affordable devices that detect respiratory pathogens in under 60 seconds using advanced microbiology and aerosol engineering. The company commercializes technology originally from WashU with an open-source model to prevent disease transmission. Based in St. Louis, USA, it targets global health by fostering collaboration and providing ultrafast, easy-to-use tools for patients and public health. Products aim to limit pandemics through accurate, low-cost testing.
Varro Life Sciences's top competitors include Noze, Poppy and Steradian Technologies.
Varro Life Sciences offers Biodetector Device and Pathogen Detection Platform.
Varro Life Sciences has 1 investor. Key investors include Vitalik Buterin.